5月8日,阿斯利康无锡小分子药物新工厂正式开工。新工厂总投资达4.75亿美元,占地约3万平方米,将装备两套前沿的片剂连续制造工艺设备和七条可持续药品包装生产线,主要生产阿斯利康在研管线中的心血管创新药,预计于2028年第四季度投产。这是继上月青岛吸入气雾剂生产供应基地一期建筑主体竣工后,阿斯利康在华供应链布局的进一步深化。(文章来源:第一财经)
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.